(PharmaNewsWire.Com, November 23, 2024 ) The global Fill Finish Manufacturing Market growth forecasted to transform from USD 16.7 billion in 2024 to USD 25.7 billion by 2029, driven by a CAGR of 8.9%. The major factors driving the growth of this market include the increasing prevalence of chronic...
(PharmaNewsWire.Com, November 22, 2024 ) Next Generation Sequencing Market is projected to reach USD 27.0 billion by 2027 from USD 13.0 billion in 2022, at a CAGR of 15.7% during the forecast period of 2022 to 2027 according to a new report by MarketsandMarkets™. The next-generation sequencing market...
(PharmaNewsWire.Com, November 22, 2024 ) The Satellites Market is estimated to be USD 17.94 billion in 2024 and is projected to reach USD 35.95 billion by 2030, at a CAGR of 12.3% between 2024 and 2030. Asia Pacific is estimated to account for the largest satellites market share in 2024. The market...
(PharmaNewsWire.Com, November 21, 2024 ) The global Lab Consumables Market is poised for significant growth, projected to rise from USD 14.41 billion in 2024 to USD 20.51 billion by 2029, driven by a CAGR of 7.3%. Key factors fueling this expansion include a heightened focus on drug discovery, increased...
(PharmaNewsWire.Com, November 20, 2024 ) The global Molecular Diagnostics Market growth forecasted to transform from $17.3 billion in 2024 to $32.7 billion by 2029, driven by a CAGR of 13.5%. There is an increased focus on funding in the areas of precision medicine and genomics by the government...
(PharmaNewsWire.Com, November 19, 2024 ) The global protein expression market is expected to reach USD 4.82 billion in 2029 from USD 3.41 billion in 2024 at a CAGR of 7.1% during the forecast period. Factors such as the rise in R&D within the pharmaceutical and biopharmaceutical industries owing...
(PharmaNewsWire.Com, November 16, 2024 ) The global Digital Dentures Market is projected to grow from USD 1.42 billion in 2024 to USD 2.16 billion by 2029, reflecting a CAGR of 8.7% during this period. This growth is primarily driven by advancements in digital technologies, notably the adoption...
(PharmaNewsWire.Com, November 15, 2024 ) The global Genomics Market is expected to reach USD 66.85 billion in 2029 from USD 42.64 billion in 2024, at a CAGR of 9.4% during the forecast period. The genomics market is rising rapidly as advancements in NGS, long-read sequencing, and CRISPR expand genomics...
(PharmaNewsWire.Com, November 14, 2024 ) The global Latent TB Testing Market is expected to grow to USD 773.4 Million by 2029, up from USD 582.5 Million in 2024, at a CAGR of 5.8% over the forecast period. The latent TB testing market is expanding due to the growing incidence of tuberculosis worldwide...
(PharmaNewsWire.Com, November 13, 2024 ) The global Antimicrobial Susceptibility Testing Market is projected to reach USD 5.68 billion by 2029 from USD 4.45 billion in 2024, growing at a CAGR of 5.0% % during the forecast period. Major driving factors for antimicrobial susceptibility market growth...
(PharmaNewsWire.Com, November 12, 2024 ) The global Synthetic Biology Market is projected to reach USD 31.52 billion in 2029 from USD 12.33 billion in 2024, with a significant CAGR of 20.6%. Rising demand for bio-based products, growing demand for personalized therapies, especially in gene and cell...
(PharmaNewsWire.Com, November 09, 2024 ) The global Al in Biotechnology Market is projected to reach USD 7.75 billion by 2029 from USD 3.23 billion in 2024, at a high CAGR of 19.1% during the forecast period. Increasing cross-industry collaborations and partnerships that foster innovation and resource...
(PharmaNewsWire.Com, November 08, 2024 ) The global aerospace testing market was valued at USD 5.29 billion in 2024 and is projected to reach USD 6.68 billion by 2029; it is expected to register a CAGR of 4.8% during the forecast period. Increasing air travel across the globe has increased the demand...
(PharmaNewsWire.Com, November 08, 2024 ) Orthopedic Devices Market in terms of revenue was estimated to be worth $36.3 billion in 2022 and is poised to reach $48.1 billion by 2028, growing at a CAGR of 4.8% from 2022 to 2028 according to a latest report published by MarketsandMarkets™. Increasing...
(PharmaNewsWire.Com, November 07, 2024 ) The global Biosimulation Market is projected to reach USD 9.18 billion by 2029 from USD 4.24 billion in 2024, at a CAGR of 16.7% from 2024 to 2029. The major factors driving the growth of the biosimulation market include the high rate of clinical trial failures,...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: